Skip to main content
Equibles
KIDS logo

KIDS · Orthopediatrics Corp

Track KIDS — free

Use KIDS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$22.41 -0.18 (-0.80%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$585.12M
Shares
26.11M

KIDS metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$22.41
Market cap
$585.12M

Price action

19 metrics
Price change (1W)
-5.2%
Price change (30D)
-3.7%
Price change (3M)
+22.3%
Price change (6M)
+24.2%
Price change (YTD)
+26.2%
Price change (1Y)
+8.2%
Trailing year
Price change (5Y)
-68.7%
52-week high
$26.50
52-week low
$14.64
Change from 52-week high
-15.4%
Change from 52-week low
+53.1%
Annualized volatility
44.1%
Beta
0.9
RSI (14D)
43.6
Price vs SMA 50
+2.8%
Price vs SMA 200
+20.9%
Avg volume (3M)
193,123
Relative volume
0.7
Average dollar volume
$4.20M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
26.11M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.5×
reciprocal yield 39.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.3×
reciprocal yield 43.2%
P / book
1.7
reciprocal yield 58.7%
FCF yield
-0.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
79.0
reciprocal yield 1.3%
Earnings yield
-6.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.0×
reciprocal yield 33.1%
EV / revenue historical average (5Y)
5.8×
reciprocal yield 17.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
73.7%
Operating margin
-11.9%
Trailing 12 months
Net margin
-15.7%
Gross profit (TTM)
$186.14M
Operating profit (TTM)
−$30.00M
Net income (TTM)
−$39.73M
Trailing 12 months
Diluted EPS (TTM)
$-1.68
FCF margin
-0.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-26.97

Growth

11 metrics
Revenue growth YoY
+15.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$252.72M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.5%
Year over year · more shares
Revenue CAGR (3Y)
+24.6%
Revenue CAGR (5Y)
+27.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-11.6%
Return on assets
-7.8%
Debt / equity
0.3
Current ratio
4.8
EBITDA (TTM)
−$7.67M
Free cash flow (TTM)
−$1.83M
Quick ratio
2.2
Interest coverage
-3.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$56.11M
Latest balance sheet
Cash & equivalents
$17.00M
Total assets
$511.39M
Total debt
$101.99M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$7.41M
Capital expenditures (TTM)
$9.24M
R&D (TTM)
$9.15M
SG&A (TTM)
—
Stock compensation (TTM)
$16.84M
R&D / revenue
3.6%
Stock compensation / revenue
6.7%

Ownership (13F)

3 metrics
13F filers
118
13F filer change QoQ
-4
Institutional ownership
62.7%

Short interest

3 metrics
Short interest
3.3%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$27.69M
Insider-sentiment score
8 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1425450 CUSIP 68752L100 13F (30d) 79 filings 79 filers Visit website Investor relations